Multiplexed phosphospecific flow cytometry enables large‐scale signaling profiling and drug screening in blood platelets
Authors:
- 1 October 2014
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 12 (10) , 1733-1743
Abstract
No abstract availableKeywords
Funding Information
- Hull York Medical School
This publication has 19 references indexed in Scilit:
- Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascadeBlood, 2010
- Screening Tests of Platelet Function: Update on Their Appropriate Uses for Diagnostic TestingSeminars in Thrombosis and Hemostasis, 2009
- Platelet Protein InteractionsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Testing antiplatelet therapyEuropean Heart Journal Supplements, 2008
- High-content single-cell drug screening with phosphospecific flow cytometryNature Chemical Biology, 2007
- Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer CellsCell, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenineCellular Signalling, 1995
- Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- On the Mechanism of Action of Theophylline and CaffeineActa Medica Scandinavica, 1985